Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling
From MaRDI portal
Publication:2894010
Recommendations
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data
- The evaluation of surrogate endpoints.
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
Cites work
- scientific article; zbMATH DE number 3976101 (Why is no real title available?)
- scientific article; zbMATH DE number 3793223 (Why is no real title available?)
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- A large sample study of rank estimation for censored regression data
- A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence
- An introduction to copulas. Properties and applications
- Asymptotic Statistics
- Bivariate Survival Models Induced by Frailties
- Comparing two failure time distributions in the presence of dependent censoring
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Efficient resampling methods for nonsmooth estimating functions
- Inferences on the Association Parameter in Copula Models for Bivariate Survival Data
- Nonparametric analysis of an accelerated failure time model
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm
- On meta-analytic assessment of surrogate outcomes
- On semi-competing risks data
- Probabilistic Principal Component Analysis
- Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data
- The Analysis of Failure Times in the Presence of Competing Risks
- The evaluation of surrogate endpoints.
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
Cited in
(7)- Testing error heterogeneity in censored linear regression
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
- Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data
- A causal framework for surrogate endpoints with semi-competing risks data
- On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
- Improving estimation efficiency for semi-competing risks data with partially observed terminal event
This page was built for publication: Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2894010)